iRadimed Corporation reported Q3 2026 revenue of $24.2 million, a 14% increase from the prior year, driven by strong sales of its new 3870 MR IV pump. Net income rose 17% to $6.5 million, with earnings per share at $0.51. The company raised its full-year 2026 revenue guidance to $91.6-$93.1 million and expects Q4 revenue of $25.0-$26.5 million. It also declared a quarterly cash dividend of $0.20 per share payable in November. This growth reflects successful product launches and increased production efficiency, positioning iRadimed for a strong year-end performance.
iRadimed Corporation reported a 17% rise in net income to $6.5 million in Q3 2026, alongside a 14% revenue increase to $24.2 million. For readers following the health sector, here is Pluang's market snapshot as of Oct 30, 2026 18:43 WIB: out of 150 priced US health stocks, 71 rose and 72 fell. Notable movers include INO at USD 0.86 with a 1-day change of +11.43%, SYK at USD 277.03 down 11.03%, and FLNA at USD 0.60 down 10.19%.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
